Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Study:

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications

Rationale:

n/a

Purpose:

This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.

Study Status: Recruiting

Recruiting:
Matt Kalaycio, MD kalaycm@ccf.org

Condition Intervention Phase
Hematological Malignancies
Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders
Hurler Syndrome (MPS I)
Krabbe Disease (Globoid Leukodystrophy)
X-linked Adrenoleukodystrophy
Primary Immunodeficiency Diseases
Bone Marrow Failure
Beta-thalassemia		 Drug: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) N/A

Verified by Center for International Blood and Marrow Transplant Research April, 2013

Sponsored by: Center for International Blood and Marrow Transplant Research
Information provided by: Center for International Blood and Marrow Transplant Research
ClinicalTrials.gov identifier: NCT01351545

Study Type: Interventional

Study Design: Time Perspective: Prospective

Cleveland Clinic
Cleveland, Ohio 44195
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.